
The perspective analyzes the developments in AI-based digital pathology from 2019 to 2024, highlighting technological innovations, regulatory changes, and commercial trends. AI has enhanced image analysis and enabled scalable solutions in oncology. However, regulatory challenges, reimbursement hurdles, and the adoption of AI in clinical oncology remain key issues. The comprehensive review provides insights into the evolving landscape and outlines the future of AI in clinical practice.
Like
Save
Share